Author: healthevolved

Obesity Stories EP 2: Meet Rob!

Explore Rob’s powerful story as he battles obesity, navigates the challenges of the Standard American Diet (SAD), and finds hope through specialized care and GLP-1 medication. Learn about the complexities of managing obesity, the importance of targeted treatment, and how Rob’s journey offers valuable insights for anyone facing similar health struggles. Watch now and be inspired to take control of your health.

Is Wegovy really worth $1,000?

Ever wondered why weight-loss drugs like Wegovy cost over $1,000 a month in the US while only $25 to make? The high prices are due to more than just manufacturing costs. Discover the impact of lobbying, research expenses, and the role of Pharmacy Benefit Managers (PBMs) in this eye-opening vlog.

Obesity Stories EP 1: Kind Kendra Creates

Watch the premiere episode of ‘Obesity Stories’ as Kendra shares her inspiring journey of losing over 100 lbs, overcoming mental health challenges, and her experiences with GLP-1 medications. Discover her lifestyle changes, struggles with loose skin, and plans for plastic surgery. Be inspired by her resilience and determination.

Can Wegovy or Ozempic Cause Blindness?

Should you worry about blindness from semaglutide? A recent study in JAMA Ophthalmology found a link between semaglutide and Nonarteritic Anterior Ischemic Optic Neuropathy (NAION), a rare eye condition. The study compared data from individuals using semaglutide for diabetes or obesity with those who weren’t.

Wegovy and Preserving Muscle Mass

Discover how to use Wegovy for effective weight loss while preserving muscle mass. Learn essential strategies for long-term health, including the importance of muscle maintenance and optimal protein intake. Get practical tips and expert insights to support your weight loss journey and improve your overall well-being.

Long-Term Results of Wegovy: Latest Findings from the SELECT Trial!

A recent study published in May 2024 unveiled a long-term outcome of Semaglutide, known as Wegovy or Ozempic. This builds on the SELECT trial, which showed Wegovy could reduce major cardiovascular events by 20% in individuals with obesity and no diabetes. Conducted by Ryan et al., the study followed participants for 208 weeks, or about four years.

Orforglipron: The New Oral GLP-1 Agonist

Meet Orforglipron, the new oral GLP-1 agonist that could revolutionize weight loss. Unlike other treatments that require careful timing, Orforglipron can be taken anytime, making it a more convenient option. Discover how it compares to popular treatments like Wegovy, exploring its effectiveness, ease of use, and potential benefits.

Bimagrumab: Lose Fat AND Gain Muscle?

Discover the groundbreaking potential of Bimagrumab, a new drug that may help you lose fat and gain muscle simultaneously. I explain the science behind Bimagrumab, its effects on obesity and muscle growth, and the promising results from recent studies. Learn about the benefits, side effects, and future implications of this innovative treatment.

Wegovy: Weight Loss Benefits vs. Kidney Health Risks

Does Wegovy, also known as semaglutide or Ozempic, help or harm your kidneys? According to some “google doctors” in my comment sections, the answer is a resounding YES! But, hold on—it’s not that simple. On the flip side, exciting new research suggests Wegovy could actually protect your kidneys!

Weight Loss with Diabetes: The Challenges and Solutions

Why is losing weight so challenging for people with type 2 diabetes? Despite fancy new medications like Zepbound, managing weight remains a tough battle for those with this condition. Interestingly, shedding pounds can actually help manage diabetes, but the disease itself makes weight loss harder.